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Environmental chemicals with estrogenic activities have been suggested to be associated with
deleterious effet in animals and humans. To characterize estrogenic chemicals and their mecha-
nisms ofaction, we established in vitro and cell culture assays that detect human estrogen recep-
tor a (hERa)-mediated estrogenicity. First, we assayed chemicals to determine their ability to
modulate direct interaction between the hERa and the steroid receptor coactivator-1 (SRC-1)
andin acompetition bindingassayto displace 17j-estradiol (E2). Scond, weteted thechemical
for estrogen-associated transcriptional activity in the yeast estrogen screen and in the estrogen-
responsive MCF-7 human breast cancer cell line. The chemicals investigated in this study were
o,p'-DDT (racemicmiu and enantiomers), nonylphenol mixtre (NPm), andtwo poorlyana-
lyzed compounds in the environment, namely, tris-4-(chlorophenyl)methane (Tris-H) and tris-4-
(chlorophenyl)methanol (Tris-OH). In both yeast and MCF-7 cells, we determined estrogenic
activity via the estrogen receptor (ER) for o,p'-DDT, NPm, and for the very first time, Tris-H
and Tris-OH. However, unlike estrogens, none ofthesexenobiotics seemed to be able to induce
ERISRC-1 interactions, mostlikely because the conformation ofthe activated receptorwould not
allow direct contacts with this coactivator. However, these compounds were able to inhibit [3H]-
E2 binding to hER, which reveals a direct interaction with the receptor. In conclusion, the
test compounds are estrogen mimics, but their molecular mechanism of action appears to be
different from that ofthe natural hormone as revealed by the receptorbcoactivator interaction
analysis. KIy work: coactivator SRC-1, environmental chemicals, estrogen receptor at, MCF-7
cells, transcriptional activity, xenoestrogen, yeast. Environ HeaLh Perspect 108:621-629 (2000).
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Estrogens influence the growth, differentia-
tion, and functions of many target organs,
such as those of the female and male repro-
ductive systems including mammary gland,
uterus, vagina, ovary, testis, epididymis, and
prostate (1,2). These steroid hormones also
play an important role in bone maintenance,
in the central nervous system, and in the car-
diovascular system where estrogens have cer-
tain cardioprotective effects (1-3). The initial
step in their mechanisms of action is their
binding to an intracellular estrogen receptor
(ER). There are two estrogen receptor iso-
types, a and [. Although ERa (NR3A1) (4)
is well characterized, only recently has ERP
(NR3A2) (4) been discovered in the rat (5),
mouse (6), and human (74. The two isotypes
differ in the C-terminal ligand binding
domain and in the N-terminal transactiva-
tion domain. The binding ofthe ligand caus-
es a conformational change in the receptor
that enables the estrogen/estrogen receptor
complex to bind as a homodimer (a/a or
[/I) or heterodimer (a/[) (8) tospecific sites
on the DNA, the estrogen response element
(ERE) (9,10). Once bound to DNA, the
estrogen/estrogen receptor complex modu-
lates the transcription oftarget genes (11,12)
through which it exerts its effects. Other
types ofaction ofsteroid hormones exist; for
estrogen, plasma membrane receptors have
been described, and many of the actions of
17[-estradiol (E2)-like compounds still
remain unanswered (13).
During the past 50 years or more, a large
number ofdiverse synthetic chemicals (xeno-
biotics) have been released into the environ-
ment because ofefforts to increase agricultural
productivity or because modern industrial
processes produce industrial waste. Thus,
each year, vast quantities ofpesticides, insecti-
cides, fungicides, herbicides, solvents, deter-
gents, styrenes, polychlorinated biphenyls,
and penta- to nonylphenols are released into
the ecosystem and accumulate in the air,
water, and food chain (14,15). As many of
these chemicals and industrial waste products
have steroidlike activity, scientists and health
officials have raised concerns about such envi-
ronmental compounds, including natural
products (e.g., coumestrol and genistein), pes-
ticides and fungicides (DDT, lindane,
methoxychlor, and vinclozolin), as well as
other commercial chemicals such as bisphe-
nol A andp-nonylphenol (16-21). By acting
as estrogen mimics (xenoestrogens) they can
disrupt normal endocrine function, possibly
leading to reproductive failure in wildlife
and humans, and can also induce tumors in
estrogen-sensitive tissues (22,23).
The molecular structure of exogenous
natural and synthetic estrogens may be very
similar to, or strikingly different from, the
natural hormone E2 (2427)4 Despite their
structural diversity, all of the exogenous
estrogens, when ingested either as natural
compounds (phytoestrogens, mycoestrogens)
or contaminants (xenoestrogens), have the
capacity to bind to the ER at a given con-
centration in target cells ofthe body and can
initiate (agonist) or inhibit (antagonist)
estrogen-like actions (16,28). In doing so,
estrogen mimics have the potential to alter,
either in a beneficial or harmful manner, the
growth, development, and function ofestro-
gen target tissues. Nonetheless, the findings
correlating environmental estrogens with
adverse human health are still the focus of
scientific debate and investigation. The well-
documented effects of environmental estro-
gens in animals and their potential for adverse
effects in humans have led to the develop-
ment of assays to identify chemicals with
estrogenic activity (25). Given that prediction
ofestrogenic potency derived from structural
information alone is not yet possible, robust
and reliable assays capable ofscreeningchemi-
cals forestrogenic activity are required.
We developed a yeast estrogen screen
(YES) by expressing the human estrogen
receptor a (hERa) in cells that have a target
gene with one copy ofthe ERE linked to the
lacZgene. Normally, yeast cells do not con-
tain nuclear receptors for steroids, but they
do possess proteins that are homologous to
mammalian cells necessary for controlling
transcription. Thus, the identification of
chemicals that induce hER transcriptional
activity is possible in the modified cells (25.
Furthermore, to examine the activities of
environmental chemicals in human cells, we
performed an estrogen-responsive reporter
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gene assay in MCF-7 cells stably transfected
with an ERE-luciferase plasmid. Finally, we
optimized and validated a novel in vitro lig-
and detector assay, the coactivator-dependent
receptor ligand assay (CARLA), previously
developed for the screening of peroxisome
proliferator-activated receptor (PPAR) lig-
ands (30), for E2 and usedthis assay to screen
putative estrogenic chemicals. This assay is
based on the direct ligand-dependent interac-
tion between the ER and the transcriptional
steroid receptor coactivator-1 ( SRC-1) after
activation ofthe receptor, which results from
aligand-induced conformational change.
We studied two poorly characterized
compounds present in the environment, tris-
4-(chlorophenyl)methane (Tris-H) and tris-
4-(chlorophenyl)methanol (Tris-OH), and
compared their activities to the organochlo-
rinated pesticide o,p'-DDT (the racemic
mixture and both enantiomers) and a mix-
ture of nonylphenols (NPm; released from
polystyrene), which have already been iden-
tified to have estrogenic activity. Tris-H and
Tris-OH have been detected as microconta-
minants in the marine environment (31).
There is a lack ofknowledge with respect to
the origin and toxicology of these com-
pounds. The possible sources of Tris-OH
include synthetic (optically active) high
polymers, agrochemicals, and dye produc-
tion (32. Another studysuggested that Tris-
OH mayalso be produced bydegradation of
Tris-H in the environment, which is
thought to be a by-product in the manufac-
ture oftechnical grade DDT (33).
In this report, we present a study of the
mechanisms ofaction ofthe estrogen mimet-
ics o,p'-DDT and NPm. Furthermore, we
have also determined for the first time that
Tris-H and Tris-OH have estrogenic activity
in cellular tests. In the CARLA test, none of
the xenobiotics studied was able to induce
interaction between ER and SRC-1; this is
similar to results with the antiestrogens ICI
182,780 and hydroxytamoxifen. We investi-
gated the abilityofsomecompounds to com-
pete with E2 for ERbinding sites by using E2
binding assays in MCF-7 cells in culture.
Materials and Methods
Chemicals reagents and culture media. We
purchased E2 and diethylstilbestrol (DES)
from Sigma (St. Louis, MO). The o,p'-DDT
was a gift from D. Ehrenstorfer (Ecole
Polytechnique Federale de Lausanne,
Lausanne, Switzerland); the nonylphenol
mixture (NPm; ring and chain isomers; puri-
ty 90%) was a gift from P. Balaguer
(INSERM, Montpellier, France); and the
ICI 182,780 was a gift from A. Wakeling
(ICI Pharmaceuticals, Alderley Park,
Macdesfield, UK). Tris-H andTris-OH were
synthesized as described below with a purity
of94%. Stocksolutions (10-2M) oftest com-
pounds were prepared in ethanol. Ethanol
concentration in the culture medium never
exceeded 0.1% (v/v) for both the yeast and
the mammalian cell cultures. Yeast medium
components were purchased from Difco
(Basel, Switzerland) and Sigma. We pur-
chased theculture mediaforstablytransfected
mammalian cells (DMEM and DMEM/F-
12) from Gibco-BRL (Basel, Switzerland).
Synthesis ofTris-H and Tris-OH. We
synthesized Tris-OH by adding 4-chlorobro-
mobenzene to 4,4'-dichlorobenzophenone by
a Grignard reaction. In a reactor under a
nitrogen atmosphere, we added 1.34 g mag-
nesium to 15 mL dry diethyl ether. The solu-
tion was stirred and heated gently to a reflux,
and then 9.74 mg (0.05 M) 4-chlorobro-
mobenzene was added. After 45 min, the
reaction mixture was cooled to room temper-
ature. Under continuous stirring, we added
15 mL dry ether and 8.41 g (0.03 M) 4,4'-
dichlorobenzophenone. The solution was
reheated until reflux. After 15 min, we
poured the reaction mixture slowly into an
ice-cooled beaker containing 20 mL 3 M sul-
furicacid. The aqueoussolution was extracted
three times with ether. Ether phases were
pooled and dried with sodium sulfate. Ether
was evaporated under reduced pressure to
obtain an oily orange solution. This mixture
was chromatographed through a 40 g Silica
gel 60 column (Merck, Darmstadt, Germany)
using petroleum ether as the solvent; after
evaporation, we obtained a white solid com-
posed of 93.5% Tris-OH and 6.5% 4,4'-
dichlorobenzophenone. Further purification
was performed on the same Silica gel 60 col-
umn using ether/hexane (1:3 v/v). After
evaporation ofsolvent, we isolated the pure
Tris-OH as a white crystalline compound
with acomposition of100% Tris-OH.
Tris-H was synthesized by reduction of
Tris-OH with sodium borohydride. We dis-
solved 1.005 g Tris-OH (96.5% purity) in
22 mL trifluoroacetic acid (stirred and cooled
to 0°C). NaBH4 (1.054 g) was added slowly,
and an exergonic reaction was observed at
each addition. The solvent was evaporated
under reduced pressure, and residues were
dissolved with 25 mL H2O and 25 mL
dichloromethane, giving two clear phases.
This mixture was washed with 100 mL ofa
2% (wt/v) sodium carbonate solution and
extracted three times with 100 mL chloro-
form. Chloroform phases were pooled, dried
with sodium sulfate, and evaporated under
reduced pressure. The residue was chro-
matographed through a 20 g Silica gel 60
column using petroleum ether as the eluate.
After evaporation, the residue was recrystal-
lized from methanol giving crystalline Tris-H
of high purity. We determined purity and
structure by gas chromatography-electron
capture detection (GC-ECD) and gas chro-
matography-mass spectrometry (GC-MS).
Plasmids. The pGEX GST-hER and
pSG5 SRC-1 plasmids (34) were a gift from
M. Parker (Cancer Research Fund, London,
UK). The p2HG-hER expression vector
(35), the p2HG plasmid (36), and the
pLGERE reporter plasmid (36) were a gift
from M. Tsai-Pflugfelder (Institut Suisse de
Recherches Experimentales sur le Cancer,
Lausanne, Switzerland).
Yeaststrain. The yeast strain used in this
study was the YRG-2 competent cell line
(MATa ura3-52 his3-200 ade2-101 lys2-801
trpl-901 leu2-3 112 gal4-542 gal8O-538
lys2::UASGALI -TATAGALl -HIS3
URA3::UASGAL4 17mers (x3)-TATACYCl-Lac2)
provided by Stratagene (Basel, Switzerland).
Yeast cellswere transformed using the lithium
acetate method (37) eitherbythep2HG-hER
expression vector and the pLGERE reporter
plasmid, which contains one ERE linked to
the lacZgene, or by the empty p2HG vector
with the same reporter plasmid. Double
transformants, with the expression vector (or
the empty vector) and the reporter plasmid,
were selected by growth on minimal plates
deficient in uracdil andhistidine.
P-galactosidase assay in yeast cells.
Transformed yeast cells were grown in syn-
thetic drop-out medium without uracil and
histidine (37) and supplemented with 2%
(wt/v) glucose, 3% (vlv) glycerol, and 2%
(wt/v) lactate. At the late log phase, the
cultures were diluted (1:50) into the same
medium without glucose, and the growth
continued for24 hr. Galactosewas added to a
final concentration of 2% (wt/v) to induce
the yeast GALl promoter. Test compounds
(E2, synthetic estrogens, antagonists, and
xenobiotics) were added as indicated during
overnight incubation. After treatment, the
cells were harvested by centrifugation (2,000
rpm for 5 min), resuspended in 1 mL of Z
buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCI, 1 mM MgSO4, and
35 mM 2-mercaptoethanol, pH 7), perme-
abilized by the addition of8.5 IpL chloroform
and 5.7 pL 0.1% (wt/v) SDS, and mixed for
10 sec at 12,000 xg. The reactionswere incu-
bated at 30°C with 200 PL o-nitrophenyl P-
D-galactopyranoside (4 mg/mL in Z buffer)
and were terminated by the addition of 500
pL 1M Na2CO3. We removed the cell debris
by centrifuging for 10 min in a microfuge at
12,000 x g and discarding the pellets. We
measured the absorbance at 420 nm and
determined the I-galactosidase activity by the
formula [optical density (OD)420/0D600 of
assayed culture x volume (milliliters) assayed
x time (min)] (37).
CARLA pul4owns. The protocol for the
CARLA has been previously described (30).
Briefly, fusion proteins of glutathione
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S-transferase (GST) and the ligand binding
domain (LBD) of the ER were bacterially
expressed and partially purified on glu-
tathione-Sepharose beads (Pharmacia,
Piscataway, NJ). Beads were incubated with
the test compounds (E2, DES, xenobiotic)
and radiolabeled SRC-1 (produced in vitro
using a coupled transcription/translation rab-
bit reticulocyte lysate system (TNT; Promega,
Madison, WI). The reaction was incubated at
40C with constant rotation, and beads were
collected by centrifugation and washed. The
glutathione-Sepharose-bound proteins were
dried under vacuum for 30 min before being
resuspended in loading buffer [62.5 mM Tris,
2% (wt/v) SDS, 10% (v/v) glycerol, 5% (v/v)
2-mercaptoethanol, pH 6.8] with bromophe-
nol blue and subjected to SDS-PAGE. Before
being dried and exposed to autoradiography,
the polyacrylamide gels were stained with
Coomassie Brilliant Blue to determine that
equal amounts offusion proteins were used in
each reaction. The amounts ofretained SRC-
1 were determined bydensitometry.
TranscHptional activation assay in stably
transfected MCF-7 cells. The MELN41 cells
(derived from MCF-7 cells) were stably trans-
fected with the reporter plasmid ERE-luc
(38). Cultures were maintained in DMEM
containing phenol red and supplemented
with 5% (v/v) fetal calf serum (FCS) and 1
mg/mL geneticin G418 (Sigma) in a 95%
air/5% CO, environment at 37°C. Cells were
grown as a monolayer under these conditions
in accordance with routine cell-culture proce-
dures. Three days before plating in Falcon 24-
well-tissue-culture plates (Becton Dickinson,
Franklin Lakes, NJ) cells were incubated in
phenol-red free DMEM/F-12 medium sup-
plemented with 3% (v/v) dextran/charcoal
stripped serum to decrease the estradiol con-
tent and the background signal. After this
period, cells were harvested by trypsinisation
[0.10% (wt/v) trypsin in 0.02% (wt/v) EDTA-
Hank's balanced salt solution] and plated at a
concentration of2 x 10-5 cells/well in 24-well
plates in the same medium as above for 24 hr.
At 80% confluency, cells were treated with
various concentrations ofthe test compounds
for 1 2 hr and were harvested to measure
luciferase activity. The Bradford protein assay
(39) was performed on an aliquot of cell
homogenate according to the instructions for
the microassay procedure (Bio-Rad, London,
UK). The experimental values are expressed as
arbitrary luminescence units per microgram
of protein. Basal activity corresponds to the
value obtained with vehicle alone.
Determination ofenvironmental chemi-
cal-binding in whole cells. We determined
binding properties of test compounds using
the MCF-7 cell line growing in monolayer
culture (40). Briefly, MCF-7 cells were seed-
ed in 24-well plates until confluency in
phenol-red free DMEM/F-12 medium sup-
plemented with 2% (v/v) dextran/charcoal
stripped serum. We removed growth medi-
um and added 0.1 nM [3H]-E2 to wells in
quadruplicate in 0.5 mL DMEM/F-12 medi-
um plus 0.1% (wt/v) bovine serum albumin
(BSA) with or without unlabeled E) or test
compounds to assess nonspecific binding.
After incubation for 1 hr at 37°C (when
binding was at the maximum), the medium
was removed and the cells were washed with
phosphate buffer [5 mM sodium phosphate,
0.25 M sucrose, and 10% (v/v) glycerol, pH
7.4)]. Cell-bound radioactivity was extracted
from the cells with ethanol and determined
by scintillation counting. The data were plot-
ted as percentage ofcontrol (specific binding
in the absence of competitor) versus the
molar excess ofcompetitor.
Statisticalanalysis. We analyzed the data
using Student's t-test. Results were consid-
ered significant when p < 0.05. The data are
presented as mean and standard deviation of
the mean.
Results
CARLA assay. A novel ligand assay for the
rapid screening of a large number of com-
pounds has been developed to characterize
synthetic and natural PPAR ligands (30). This
assay is based on the ligand-induced binding
of SRC-1 to nuclear hormone receptors (34).
In the case ofxenoestrogens, we hypothesized
that potential ligands for ERa would induce
ER/SRC-1 interactions only in cases where a
direct and specific binding of compounds to
the LBD ofthe ERoccured (Figure IA).
SRC-1 was expressed and labeled with
[35S]-methionine, and the LBD of ER was
expressed in Escherichia coli as a fusion pro-
tein with glutathione-S-transferase (GST).
To optimize and validate the interaction
assay, we performed GST pull-down assays
in the presence ofE, at concentrations rang-
ing from 10 l M to 10-6 M. We observed
no interaction of[35S]-SRC-1 with GST-ER
LBD in the absence of hormone. As shown
in Figure IB, E2 induced interactions ofthe
receptor with SRC-1 in a concentration-
dependent manner. Similar results were
obtained with DES (data not shown). In
contrast, none of the four environmental
chemicals tested (o,p'-DDT, NPm, Tris-H,
and Tris-OH) nor the antiestrogens ICI
182,780 and tamoxifen (data not shown)
was active in this test at concentrations up to
10-4 M, which was the solubility limit for
most ofthe compounds (Figure 1C).
Receptor bindingstudies. To screen envi-
ronmental pollutants for possible interac-
tions with ER, we measured displacement by
xenobiotics of[3H]-E2 bound to ER in MCF-
7 cells growing in monolayer culture. Cells
were incubated with 0.InM [3H]-E2 in the
presence or absence ofvarying concentrations
of nonlabeled chemicals. Figure 2 shows that
specific [3H]-E2 binding was completely
inhibited by a 100-fold molar excess (10-8 M)
of unlabeled E2, with a concentration neces-
sary to inhibit the binding of[3H]-E2by 50%
(IC50) at approximately 4-fold excess, that is,
at 0.4 x 10-9 M. All test compounds were
able to displace [3H]-E2 from the hER.
Unlabeled (-) o,p'-DDT inhibited binding by
approximately 86% at 10-4 M. At the same
concentration, (+) o,p'-DDT inhibited the
binding by approximately 73%. Tris-OH and
Tris-H caused a decrease in [3H]-E2 binding
by approximately 80% and 75%, respectively,
at a concentration of 10-4 M. The1C50 value
was approximately 10-7 M for both com-
pounds. These results demonstrate that these
compounds may act by a direct interaction
with hER.
Effects ofxenobiotics on the transcription-
al activity ofhER in yeast. We used a yeast
system that expresses hER to screen the estro-
genic potential of the environmental pollu-
tants. The YRG-2 yeast strain contains an
estrogen-responsive reporter gene built with
one copy ofthe consensus ERE linked to the
yeast CYC 1 promoter located upstream of
the E. coli gene for 3-galactosidase (lacZ4.
Xenobiotics belonging to various classes of
compounds, i.e., pesticides and plasticizers,
were tested. Yeast cells were grown overnight
at 30°C in liquid culture in the absence or
presence ofincreasing concentrations ofE2 or
a xenobiotic. We assessed sensitivity and
reproducibility of the assay by measuring the
response to E2.
Figure 3 illustrates the concentration-
dependent effects of 10- 1_10-6 M E2 and
10-1010-6 M DES in the YRG-2 yeast strain.
The 3-galactosidase activity was dose depen-
dent up to concentrations of10-7 10-6 M and
then reached a plateau for both ER agonists.
DES was less efficacious than E2 at inducing
P-galactosidase activity (Figure 3A). We test-
ed a range of chemical concentrations from
10-8 M to 10-5 M to validate our assay and to
assess if it detects estrogen-like responsiveness
to known xenoestrogens. Thus, the P-galac-
tosidase activity was significantly induced by
o,p'-DDT and the other known xenoestro-
gen, NPm, at each concentration tested in a
dose-dependent manner and with a maximal
effect at 10-5 M (Figure 3B). At 10-5 M,
racemic o,p'-DDT increased 1-galactosidase
activity by 3.2-fold, corresponding to 41% of
the activity induced by 10-7 M E2. NPm at
10-5 M induced f-galactosidase activity to a
level similar to that of o,p'-DDT. These
results demonstrate that our system is respon-
sive to xenoestrogens.
Figure 4 provides evidence that Tris-H
andTris-OH are estrogenic. In the yeast assay,
this effect was studied at high concentrations
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ranging from 10-6 M to 104 M. Both com-
pounds increased 0-galactosidase activity to
reach 70% of the activity with E2, although
the activity decreased with 104 M Tris-OH
for unknown reasons. This indicates partial
agonistic activity in this test. The same com-
pounds werealso tested using the YRG-2 yeast
strain, which does not express hER (Figure 4).
There was no induction of the lacZgene in
the presence of E2 or the test compounds.
Taken together, these results indicate that the
estrogenic activity detected in our yeast sys-
tem that expresses hER is the result of an
interaction between the receptor protein and
the xenobiotics or their metabolites, and not
a consequence of an unspecific activation of
the basal transcriptional machinery.
Further control experiments (Figure 5)
revealed that in the YRG-2 strain, the potent
antiestrogen ICI 182,780 was not able to
antagonize E2 activity even when a 100-fold
molar excess was used. More interestingly,
when tested alone, ICI 182,780 exhibited full
agonist activity. This result is in agreement
with the findings ofKohno et al. (41) with a
different yeast strain. Tamoxifen also had an
agonist activity in this assay (data not shown).
These latter results prompted us to use a
mammalian cellular system, in which this
antiestrogen behaves as a pure antagonist
(42-44).
ERE-luciferase reporter gene in stably
transfectedMCF-7cels. To examine the abil-
ity of the environmental chemicals to trigger
hER-mediated transcriptional activation in
mammalian cells, we used MCF-7 human
breast cancer cells that were stably transfected
with a plasmid containing one ERE copy
linked to the luciferase gene. The cells were
incubated in the presence or absence of
increasing concentrations of E2 or the envi-
ronmental chemicals for 12 hr; extracts were
then assayed for luciferase activity. Figure 6
illustrates the concentration response curve
for the range from 10-12 M to 10-6 M E2. The
median effective concentration (EC50) value
for E2-induced response was approximately
10-10 M. The maximal luciferase induction
was observed at a concentration of 10-8 M.
Thus, 10-8 M E2 was included as a positive
control in further experiments to serve as a
reference for comparison with other chemi-
cals. As shown in Figure 7A, both the racemic
mixture and the enantiomers of the
organochlorinated compound o,p'-DDT
were effective at inducing luciferase activity.
In each case, the maximal induction was
observed at the highest concentration tested
(10-5 M). A concentration of 10-4 M was
toxic (data not shown). The L-enantiomer of
o,p'-DDT was the most efficacious com-
pound at 10-5 M, even more than E2 at
10-8 M (124% ofE2 effect), indicating that it
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Figure 1. Ligand-dependent interaction in vitro between ERa and SRC-1. Abbreviations: (input), amount of [35S]-SRC-1 used in each reaction; M, molecular
weight marker. (A) CARLA assay protocol. See "Materials and Methods" for details. The binding of a ligand enhances the interaction between the nuclear recep-
tor LBD and the SRC-1, and thus, the amount of pulled SRC-1 in the presence of a ligand was higher than in the absence of ligand (solvent or nonligand com-
pound). (B) In vitro translated and [35S]-labeled SRC-1 was incubated with GST-ER in the presence of various concentrations of E2. The relative CARLA value of
100 for E2 corresponds to the amount of SRC-1 retained by ER LBD in the presence of 10-6M E2. (C) In vitrotranslated [35S]-labeled SRC-1 was not retained on GST-
fusion proteins of the ERa LBD in the presence of environmental chemicals. ICI 182,780, an antiestrogen, was used as as a negative control. NPm was used at
concentrations ranging from 100 nM to 10 pM and the other compounds at concentrations ranging from 100 nM to 100 pM according to theirsolubiiity.
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tion. As in the yeast system, NPm, Tris-H,
and Tris-OH also exhibited hER-mediated
estrogenicity in MCF-7 cells (Figure 7B).
However, the two latter chemicals did not
yield hyperbolic dose-response curves. Tris-
H and Tris-OH showed a statistically signifi-
cant weak effect from a concentration of
10-8 M, but they were much less potent and
efficacious than E2 and the other test com-
pounds. NPm (10-5 M) induced luciferase
activity to an extent similar to E2, indicating
that it might also be a full agonist ofthe hER
(Figure 7B).
To demonstrate that the effects of the
chemicals were mediated by the hER, we
incubated MCF-7 cells in the presence of
environmental chemicals alone or together
with 10-6 M ICI 182,780, a pure ER antag-
onist in these cells. The luciferase activity
induced by all of the chemicals tested was
abolished completely in the presence of ICI
182,780 (Figure 8), demonstrating that the
chemicals interact in a specific manner with
the hER in this cellular assay. We also
observed that after pretreatment with 3%
dextran/charcoal stripped serum, the MCF-7
stably transfected cells were not completely
devoid of E2 because ICI 182,780 was able
to decrease the solvent value. This could be
due to residual estrogens present in the
serum, as we have observed the capability of
these cells to respond to lower E2 levels.
Alternatively, there was a weak E2-indepen-
dent activity ofthe ER that possibly resulted
from hormone-independent signaling as
described previously (45).
Discussion
Several natural and man-made chemicals have
been labeled as endocrine disruptors, with
most ofthem exhibiting estrogen-like activity
(46,47). As a result, there are numerous
examples ofreproductive anomalies in wildlife
in areas contaminatedwith chemicals that dis-
play hormone-like activity (15). Essential for
the understanding ofpotential hazards is the
determination of whether these chemicals
interact directlywith steroid receptors, such as
the estrogen receptors. Several in vitro assays
have been developed to screen chemicals for
estrogenic activity, including yeast-based
screens (29), the MCF-7 cell proliferation
assay (48), estrogen-responsive reporter gene
assays (49), and ERbinding assays (50,51).
In vitro test systems: advantages and
drawbacks. We used a combination ofcom-
plementary assays to study the estrogenic
activity of different environmental pollu-
tants. This combination of in vitro tech-
niques includes the GST-pulldown assay
(CARLA test), which detects interactions
between ERand a coactivator; a competition
binding assay that assesses ligand interactions
with the receptor; a yeast-based estrogen
receptor assay (YES); and a luciferase
reporter assay in cultured MCF-7 cells that
reveals transcriptional activation.
The CARLA test and the competitive
binding assay are not able to discriminate
between estrogenic and antiestrogenic prop-
erties of environmental chemicals, but they
can give useful and important information
about the interaction of these chemicals
with the ER and the molecular mechanism
oftheir action.
The advantages of the YES assay for
assessing chemical interactions with ER are its
specificity and its ease of manipulation.
Indeed, it is a simple eukaryotic system in
which estrogenic responsiveness is primarily
due to the ligand binding properties of the
ER and its ability to stimulate the basal tran-
scription machinery (52). However, an
important drawback to this assay is its respon-
siveness to antiestrogens (41,53); another dis-
advantage is that the thick cell wall of the
yeast limits permeability of substances (54).
In earlyexperiments, we used the GA 24 yeast
strain, which had a high estrogen sensitivity
but was unresponsive to xenobiotics (data not
shown). Therefore, we chose the YRG-2
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Figure 2. Inhibition of [3H1-E2 binding by environmental chemicals. Some compounds tested in the CARLA
assay were measured fortheir abilityto inhibitthe binding of [3H1-E2 to hER by displacing it in competition
binding assays. MCF-7 cells growing in monolayer culture were incubated with 0.1 nM [3H1-E2 for 1 hr at
37°C in the absence or presence of increasing concentrations of radioinert E2, (-) o,p-DDT, (+) o,p-DDT,
Tris-H, or Tris-OH. The data are plotted as the percentage of control in which specific binding in the
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Figure 3. Effect of E2, DES, and established estrogenic compounds on the transcriptional activity of hER in
YRG-2 yeast cells, which express hER and contain the reporter plasmid pLGERE. Yeast cells were grown
in medium containing increasing concentrations of E2, DES, o,p'-DDT, NPm, or vehicle (EtOH). Following
overnight incubation the cultures were assayed for 0-galactosidase activity (see "Materials and
Methods" for details). Values represent the 1-galactosidase induction relative to the solvent control.
Values are mean ± SD of at least two independent experiments in triplicate.
*p < 0.05 versus solvent control.
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strain that demonstrated responsiveness to
both estrogens and xenoestrogens. Animal
cells are much more sensitive to environmen-
tal conditions as compared to yeast and allow
screening of substances for both estrogenic
and antiestrogenic properties.
We concentrated our research on two
poorly studied compounds, Tris-H and Tris-
OH, and compared their activity with the
already known xenoestrogens op'-DDT and
NPm. For o,p'-DDT, we analyzed both the
racemic mixture and the two enantiomers.
Screenjing by CARLA. The CARLA pro-
vided information on the interactions between
the ligand and the receptor. Recently, several
coactivators were shown to be involved in
transcriptional activation through nuclear hor-
mone receptors (55,56); therefore, multiple
proteins have been identified to interact with
ERox in a ligand-dependent manner. This
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property was used in the CARLA to identify
potential ER ligands with a specific interac-
tion between the coactivator SRC-1 and the
fusion protein GST-ERca LBD.
Our results demonstrate that, in contrast
to E2, none of the environmental pollutants
tested was able to induce an interaction
between SRC-1 and the ERo LBD. However,
all of the chemicals investigated stimulated
the ER-mediated transcriptional activity of
either the reporter lacZ gene in yeast or the
luciferase reporter gene in MCF-7 cells.
Furthermore, o,p'-DDT (racemic mixture
and enantiomers), Tris-H, and Tris-OH
were able to displace E2 from its binding site,
which provides additional support in favor
ofa direct interaction between the xenobiot-
ic and the estrogen receptor.
Furthermore, we observed that ICI
182,780, o,p'-DDT, Tris-H, and Tris-OH
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Figure 4. Response of YRG-2 yeast cells, which contain the reporter plasmid pLGERE and that express or
do not express hER, to Tris-H (A) and Tris-OH (B). Following overnight incubation the cultures were
assayed for the ,B-galactosidase activity (see "Materials and Methods" for details). Values represent the
P-galactosidase induction relative to the solvent control. Values are mean ± SD of at least two indepen-
dent experiments in triplicate.
*p< 0.05 versus solvent control.
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Figure 5. Effects of the antiestrogen ICI 182,780 in
YRG-2 yeast cells that were transformed with
plasmids expressing hER and the estrogen
response element linked to the lacZ gene. Yeast
cells were grown overnight in medium containing
10-8 M E2, 10-6 M ICI 182,780, or both together.
Cells were harvested and assayed for ,-galac-
tosidase activity (see "Materials and Methods"
for details). Values represent the f-galactosidase
induction relative to the solvent control. Values
are the mean ± SD of at least two independent
experiments in triplicate.
*p < 0.05 versus solvent control.
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Figure 6. Induction of luciferase activity in MCF-7
cells by E2. MCF-7 cells at 80% confluency and
stably transfected with the reporter plasmid ERE-
luc were treated with increasing concentrations
of E2. Data are presented as mean ± SD and rep-
resent three independent experiments represent-
ing six measurements.
*p < 0.05 versus solvent control.
were able to inhibit E2-dependent interaction
of SRC-1 with the ER LBD. However, the
extent of inhibition, although always
observed, varied from one experiment to the
other for as yet unknown reasons. By con-
trast, the addition ofthe thyroid hormone tri-
iodothyronine, which is not a ligand of ER,
had no effect on this E2-dependent interac-
tion. These results also suggest that the pollu-
tants tested are able to bind directly to the
ER. However, xenobiotics would not allow
an interaction between the nuclear receptor
and the coactivator SRC-1. It is likely that
different molecules influence interactions of
ER with coactivators other than SRC-1.
Thus, each chemical or group of chemicals
may use a distinct coactivator to regulate ER-
mediated transcription. Using the yeast-two
hybrid assay (GAL4 DBD-ER LBD and
GAL4 AD-coactivator fusion proteins),
Nishikawa et al. (57) showed that 10-6 M
NPm was inactive with respect to SRC-1,
which is in agreement with our results, but
appeared to activate the ER via TIF-2. In our
case, it seems likely that the chemicals tested
recruit coactivators distinct from SRC-1 to
interact with the ER. It is also possible to
explain these results by different ligand selec-
tivity of ER for coactivator binding. The
absence ofan effect ofthe compounds inves-
tigated in the CARLA merely excludes an
action of these compounds via SRC-1, but
does not rule out an activation of ER. The
results obtained in the CARLA provided evi-
dence for a molecular mechanism ofaction of
the test compounds via hER that is distinct
from that ofE2.
Inhibition of13H]-E2 binding. The
results obtained in our displacement experi-
ments using radiolabeled E2 demonstrate a
direct interaction between the test com-
pounds and the hER, but the affinities were
lower than those for unlabeled E Tris-H and
Tris-OH were able to inhibit [ H]-E, bind-
ing to the hER at concentrations for which
they were active in transactivation assays. The
displacement obtained with 1,000-10,000-
fold molar excess of Tris-H and Tris-OH is
approximately 60-70%. This is a drastic
decrease in comparison with the results
obtained in the MCF-7 transactivation assay.
Indeed, the luciferase activity was induced by
2- to 3-fold. Several explanations are possible.
The compounds might effectively displace the
natural hormone, but they have less affinity
for the receptor than estradiol. Also, we can-
not exclude that the conformation of the
receptor after binding to the test compound is
not appropriate to fully activate the luciferase
reporter gene. Furthermore, the comparison
of both o,p'-DDT enantiomers revealed that
the L-enantiomer was more active in inhibit-
ing [3H]-E2 binding to the hER. This is in
agreement with the results obtained in the
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Figure 7. Induction of luciferase activity in MCF-7 cells by environmental chemicals. MCF-7 cells at80% confluency and stablytransfected with the reporter plasmid
ERE-luc were treated with increasing concentrations of environmental chemicals or vehicle. (r) o,p'-DDT, racemic mixture. E2 (10-8 M) was used as reference (con-
centration required to obtain the highest activity). Data are presented as mean ± SD and representthree independent experiments representing six measurements.
*p < 0.05 versus solvent control.
transactivation assay performed in MCF-7
cells because it showed the greatest activity at
this concentration.
Cellular assays. Our studies show that
the L-enantiomer of o,p'-DDT is more
potent than the D-enantiomer in regulating
ER-mediated cellular response in MCF-7
human breast cancer cells. It displays full
agonist activity on the ER, reaching the
maximal effect at 10-5 M. o,p'-DDT had a
stronger effect in stably transfected MCF-7
cells than in yeast, suggesting a higher sensi-
tivity of the mammalian cellular system.
More interestingly, we showed that this pes-
ticide could trigger hER-mediated transcrip-
tional activation in MCF-7 cells at low con-
centrations (10- M). o,p'-DDT has previ-
ously been shown to have estrogenic activity
in the rat (58,59) and in in vitro assays
(49,60). Most research on o,p'-DDT has
been performed using the racemic mixture.
Nevertheless, Mc Blain (61) showed that the
estrogenic activity of o,p'-DDT resides
essentially with the i -enantiomer.
As for o,p'-DDT, our results indicate that
nonylphenol (an estrogenic xenobiotic
released from modified polystyrene) displayed
its greatest estrogenic activity in the in vitro
cellular tests at a concentration of 10-5 M.
The comparison between both cellular assays
revealed that 10-5 M nonylphenol had much
more estrogen-like activity on reporter gene
expression in mammalian cells than in yeast.
A statistically significant effect was obtained at
10-6 M nonylphenol in MCF-7 cells and at
10-8 M in yeast. Therefore, nonylphenol
seems to be more efficacious in yeast than in
mammalian cells. In MCF-7 cells, nonylphe-
nol appeared to be a full agonist of hER-
mediated transactivation because it increased
luciferase activity to the same extent as E2'
albeit at a higher concentration. Balaguer et
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Figure 8. Inhibition of environmental chemical-induced luciferase activity by the antiestrogen ICI 182,780.
MCF-7 cells stably transfected with pERE-luc were treated with vehicle, E2, or environmental chemicals in
the presence or absence of 10-6 M ICI 182,780. Data are presented as mean ± SD and represent three
independent experiments representing six measurements.
*p < 0.05.
al. (62) obtained the greatest activity ofNPm
at this concentration, but in their case, the
sensitivity of the MCF-7 stable transfectants
to E2 was higher. Differences between their
results and our study could be attributable to
the use of a different clone ofstable transfec-
tants or to the dextran/charcoal stripped
serum prepared. Nonylphenol has been
shown to induce proliferation of human
breast cancer cells and to trigger mitotic activ-
ity in the rat endometrium (63). In a stably
transfected ER-mediated luciferase reporter
gene assay in the human T47D breast cancer
cell line, this chemical was one of the most
potent xenoestrogens tested, with an EC 0 of
260 nM (60). Nonylphenol has also been
shown to inhibit [3H]-E2 binding to the ER
ofrainbow trout and to stimulate vitellogenin
gene expression in this species (64). Danzo
(51) demonstrated that 10-4 M nonylphenol
caused a dramatic decrease in [3H]-E2 bind-
ing (75%), indicating that the effect is medi-
ated via the ER.
So far, no data are available concerning
the endocrine-disrupting effects of Tris-H
and Tris-OH. The data presented here using
in vitro cellular tests provide evidence for the
first time of the ability of both compounds
to modulate ER-mediated transactivation in
yeast and in human breast cancer cells. In
these two reporter gene assays, both chemicals
acted as weak agonists of hER. The 10-4 M
concentration of Tris-H and Tris-OH could
not be tested in MCF-7 cells because ofcellu-
lar toxicity. Tris-H and Tris-OH have been
found in fish, birds, and marine mammals
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fromvarious parts oftheworld (65). Tris-OH
concentrations in marine mammals from the
North Sea are approximately 1-2 mg/kg on a
lipid weight basis. Tris-H and Tris-OH are
highly bioaccumulative, and a 10- to 100-fold
biomagnification from fish to marine mam-
mals has been suggested. Tris-OH has also
been detected in human milk at low levels
(parts per billion), 2-3 orders ofmagnitude
lower than levels of other organochlorines
detected (66).
The results obtained in cellular tests
showed that the compounds analyzed act via
the ER In addition, the data indicate that
the yeast system can accurately predict the
estrogenic activity of various chemicals in
the mammalian cell system. When using cel-
lular tests, itshould be kept in mind that the
permeability of the xenobiotics through the
cell membrane can differ because of their
distinct chemical structures. In other words,
the differences observed between the two
cellular sytems tested might reflect different
uptake ofthe compounds bythe cells.
The ability ofa chemical to bind to the
ER and to activate estrogen-mediated
transactivation through the ER may be
indicative ofestrogenic activity in the whole
organism. We do not believe that these in
vitro assays alone can determine how strong
these chemicals are as endocrine disruptors
in vivo. Indeed, the in vitro assays cannot
take into account the accumulation, metabo-
lism, and availability of the compound in
the body to the target cells, or the alternate
pathways forendocrine disruption. But these
in vitrotests can serve as useful tools to assess
the endocrine-disrupting characteristics
ofchemicals.
Our data confirm o,p'-DDT and NPm
to be xenoestrogens and, more interestingly,
for the first time, identify Tris-H and Tris-
OH as estrogen mimics. Moreover we show
that o,p'-DDT (racemic mixture and both
enantiomers), as well as Tris-H and Tris-
OH, act at low concentrations (nanomolar);
this might have important consequences for
living organisms in a contaminated environ-
ment. These chemicals act directly via the
ER, but their mechanism ofaction seems to
be different from that of E2. However, the
impact of environmental Tris-H and Tris-
OH on the development, reproduction, and
health of wildlife and humans has yet to
bedetermined.
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